Delisting riskPopularity #5,333
KPRX · NASDAQ · Biotechnology

Kiora Pharmaceuticals (KPRX)

Develops intravitreal photoswitch and DHODH-inhibitor candidates for retinal degeneration and inflammation.

$2.76
After hours+0.02 (+0.73%)
At close$2.74(+2.24%)
  1. Kiora (KPRX) Q2 Revenue Falls 100%

    The Motley Fool